Combination treatment with antioxidants and creatine alleviates common and variant-specific mitochondrial impairments in Leber’s hereditary optic neuropathy patient-derived fibroblasts
Human Molecular Genetics · 2025
DOI: 10.1093/hmg/ddaf125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2025. Verfasst von Donald Xhuti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, McMaster University Medical Centre, 1200 Main Street West, Hamilton, ON L8S 3Z5, Canada. Hauptthemen laut MEDLINE: Optic Atrophy, Hereditary, Leber, Antioxidants, Mitochondria, Creatine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR, MitoCanada, Natural Sciences and Engineering Research Council of Canada Student Research.
Abstract (Originalsprache)
Leber’s hereditary optic neuropathy (LHON) is characterized by painless and rapidly progressive central vision loss, caused by various mutations in mitochondrial DNA, leading to a high genetic and phenotypic heterogeneity. Currently, the only approved therapy is idebenone, a CoQ10 synthetic analogue, that improved visual acuity in some LHON patients; however, results are highly variable due its dependency on functional NAD(P)H oxidoreductase I (NQO1) protein levels, thus limiting broader applicability. Targeting the biochemical respiratory chain defect and mitigating reactive oxygen species emission using alternative treatments which act independent of NQO1 protein content, represent a promising therapeutic strategy for all LHON patients. Here, we first characterized mitochondrial biology of three distinct LHON mutations in patient-derived fibroblasts and evaluated the effects of a nutraceutical combination treatment in addressing these shared pathophysiological mechanisms. We identified a range of mitochondrial characteristics common among various LHON mutations, including higher ROS levels, altered autophagy programming, and reduced mitochondrial bioenergetics. Repeated antioxidant and creatine-based treatment (ACT) conferred a favorable stress-resistant phenotype in LHON cells, which was similar to, and in some cases superior to, the effects observed with idebenone treatment, irrespective of NQO1 protein expression. This phenotype was associated with enhanced mitochondrial biology, as evidenced by reduced reactive oxygen species levels, increased cellular respiration, and correction of autophagic flux. Overall, our findings reveal both common and divergent mitochondrial phenotypes among LHON-related mutations and highlight the potential of accessible multi-ingredient nutraceutical interventions that could benefit all LHON patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, McMaster University Medical Centre, 1200 Main Street West, Hamilton, ON L8S 3Z5, Canada.
- Department of Kinesiology, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4L8, Canada.
- Exerkine Corporation, McMaster University Medical Centre, 1200 Main Street West, Hamilton, ON L8S 3Z5, Canada.
ORCID-Profile: Joshua P Nederveen
Förderung
- CIHR
- MitoCanada
- Natural Sciences and Engineering Research Council of Canada Student Research
- Muscular Dystrophy Canada Research Fellowship
- Neuromuscular Disease Network for Canada
- Canadian Institutes of Health Research
Zitieren
APA
Xhuti, D., Chiarot, A., Minhas, M., Tobia, S., de Maat, N., Manta, K., Ng, S. Y., Tarnopolsky, M. A., & Nederveen, J. P. (2025). Combination treatment with antioxidants and creatine alleviates common and variant-specific mitochondrial impairments in Leber’s hereditary optic neuropathy patient-derived fibroblasts. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf125
Vancouver
Xhuti D, Chiarot A, Minhas M, Tobia S, de Maat N, Manta K, et al. Combination treatment with antioxidants and creatine alleviates common and variant-specific mitochondrial impairments in Leber’s hereditary optic neuropathy patient-derived fibroblasts. Human Molecular Genetics. 2025. doi:10.1093/hmg/ddaf125
BibTeX
@article{Xhuti2025,
author = {Xhuti, Donald and Chiarot, Alessandra and Minhas, Mahek and Tobia, Samantha and de Maat, Nicoletta and Manta, Katherine and Ng, Sean Y and Tarnopolsky, Mark A and Nederveen, Joshua P},
title = {Combination treatment with antioxidants and creatine alleviates common and variant-specific mitochondrial impairments in Leber’s hereditary optic neuropathy patient-derived fibroblasts},
journal = {Human Molecular Genetics},
year = {2025},
doi = {10.1093/hmg/ddaf125}
}
EUVIMED